[PDF][PDF] Why is WHO pushing back on a Health Canada–approved Medicago SARS-CoV-2 vaccine?
The spokesperson did not answer questions about how Medicago manages potential
conflicts of interest, nor directly address concerns about its association with the tobacco …
conflicts of interest, nor directly address concerns about its association with the tobacco …
Covid-19: WHO set to reject Canadian plant based vaccine because of links with tobacco industry
O Dyer - 2022 - bmj.com
A unique plant based coronavirus vaccine newly approved in Canada is unlikely to be listed
for emergency use by the World Health Organization, a WHO official has warned, because a …
for emergency use by the World Health Organization, a WHO official has warned, because a …
[PDF][PDF] Canada's COVID-19 Vaccine Task Force needs better transparency about potential conflicts of interest
We all want the government to proactively make decisions so that once a vaccine is
approved, it can be quickly delivered to Canadians. But how are those decisions being …
approved, it can be quickly delivered to Canadians. But how are those decisions being …
[HTML][HTML] Philip Morris ejected from Canadian vaccine collaboration
T Kirby - The Lancet Respiratory Medicine, 2023 - thelancet.com
Anti-tobacco advocates are celebrating after tobacco company Philip Morris International
was finally ejected from a collaboration producing the only COVID-19 vaccine to be …
was finally ejected from a collaboration producing the only COVID-19 vaccine to be …
Why emergency COVID vaccine approvals could pose a dilemma
D Cyranoski - Nature, 2020 - nature.com
Once a vaccine is granted emergency approval, there is pressure on developers to offer the
immunization to trial participants who received a placebo. But if too many people cross over …
immunization to trial participants who received a placebo. But if too many people cross over …
How to leverage the Medicare program for a COVID-19 vaccination campaign
N Lurie, B Experton - JAMA, 2021 - jamanetwork.com
Although the Medicare program is primarily an insurance program, it serves additional
functions by virtue of its population-wide coverage (individuals older than 65 years, as well …
functions by virtue of its population-wide coverage (individuals older than 65 years, as well …
Problems with paying people to be vaccinated against COVID-19
EA Largent, FG Miller - Jama, 2021 - jamanetwork.com
TheUSFoodandDrugAdministrationhasissu…-gency Use Authorization for 2 vaccines for the
preventionofcoronavirusdisease2019 (COVID-19). Thisimpressive scientific achievement …
preventionofcoronavirusdisease2019 (COVID-19). Thisimpressive scientific achievement …
Covid-19: Moderna seeks to exclude US government scientists from vaccine patents, despite public investment
O Dyer - 2021 - bmj.com
A behind-the-scenes struggle between the drug company Moderna and the US government
over the intellectual property rights of the company's coronavirus vaccine seems to be …
over the intellectual property rights of the company's coronavirus vaccine seems to be …
Regulatory decision-making on COVID-19 vaccines during a public health emergency
J Avorn, A Kesselheim - Jama, 2020 - jamanetwork.com
Vaccine development and use depend on data-driven assessment of benefits and risks, first
by regulatory bodies, and then more subjectively, millions of times over, by individual …
by regulatory bodies, and then more subjectively, millions of times over, by individual …
Covid-19: FDA plans strict vaccine approval criteria, angering Trump
O Dyer - 2020 - bmj.com
The US Food and Drug Administration (FDA)“will not delay, but will not cut corners” in
approving a covid-19 vaccine, its commissioner Stephen Hahn promised a Senate hearing …
approving a covid-19 vaccine, its commissioner Stephen Hahn promised a Senate hearing …